Related content

Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation

By Orvieto Raoul   Zagatsky Irina   Yulzari-Roll Vered   la Marca Antonio   Fisch Benjamin  

Gynecological Endocrinology, Vol. 22, Iss. 8, 2006-08 ,pp. : 437-440

Informa Healthcare

Access to resources Recommend Favorite

Soluble L-selectin levels during controlled ovarian hyperstimulation

By Orvieto R.   Ben-Rafael Z.   Schwartz A.   Abir R.   Fisch B.   La-Marca A.   Bar-Hava I.  

Gynecological Endocrinology, Vol. 15, Iss. 1, 2001-02 ,pp. : 29-33

Informa Healthcare

Access to resources Recommend Favorite

Insulin resistance and free androgen index correlate with the outcome of controlled ovarian hyperstimulation in non-PCOS women undergoing IVF

By Dickerson E.H.   Cho L.W.   Maguiness S.D.   Killick S.L.   Robinson J.   Atkin S.L.  

Human Reproduction, Vol. 25, Iss. 2, 2010-02 ,pp. : 504-509

Oxford University Press

Access to resources Recommend Favorite

Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol

By Orvieto Raoul   Volodarsky Michael   Hod Eduard   Homburg Roy   Rabinson Jacob   Zohav Efraim   Anteby Eyal   Meltcer Simion  

Gynecological Endocrinology, Vol. 23, Iss. 8, 2007-08 ,pp. : 494-496

Informa Healthcare

Access to resources Recommend Favorite

Controlled ovarian hyperstimulation in women with polycystic ovarian syndrome with or without intrauterine insemination

By Wiser Amir   Shalom-Paz Einat   Reinblatt Shaune Leigh   Holzer Hananel   Tulandi Togas  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 502-504

Informa Healthcare

Access to resources Recommend Favorite